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Introduction. Unsatisfactory consequences of bone regeneration disorders in diabetes mellitus (DM) patients, their high prevalence,
complication number, and difficulties in treatment require further study and deeper understanding of reparative osteogenesis
mechanisms under chronic hyperglycemia and finding new effective and affordable approaches to their treatment. Therefore,
the aim of our work was to study the histological, ultramicroscopic, and histomorphometric features of reparative osteogenesis
in rats with chronic hyperglycemia (CH), as well as to investigate the possibility of platelet-rich plasma (PRP) use in a fracture
area in order to correct the negative effects of CH on reparative osteogenesis processes. Study Object and Methods. The studies
were performed on 70 white laboratory rats, mature males, which were divided into the following groups: control group,
animals with posttraumatic tibial defect under conditions of CH exposure, rats with experimental CH that were administered
with PRP into the bone defect, and animals for the assessment of glucose homeostasis and confirmation of simulated CH. Light
microscopy was performed using an Olympus BH-2 microscope (Japan). Ultramicroscopic examination was performed using
REM-102 scanning electron microscope. The statistical analysis was performed using SPSS-17 software package. Results. The
formation of new bone tissue in animals with CH did not occur after two weeks. Only on the 30th day of reparative osteogenesis
the newly formed woven bone tissue was 61.54% of the total regenerated area. It was less than the reference value by 22.89%
(P < 0:001). On the 14th day of reparative osteogenesis, the regenerated area in a group of animals with CH and PRP injection
consisted of connective tissue by 68.94% (4.94% less than in animals with CH (P < 0:001)) and woven bone tissue by 31.06%,
(13.51% less than in the control group (P < 0:001)). On the 30th day, the area of woven bone tissue in a regenerate of this group
was less than that of the control group by 12.41% (P < 0:001). Conclusion. Thus, chronic hyperglycemia contributes to
inflammation delay within the bone defect site, which makes the process of reparative osteogenesis more prolonged. The results
of chronic hyperglycemia effect on bone regeneration are also impairment of osteogenic cell proliferation and shift of their
differentiation towards the fibrocartilage regenerate formation. The PRP corrects the negative impact of chronic hyperglycemia
on reparative osteogenesis, promoting more rapid inflammatory infiltrate removal from the bone defect site and osteogenic
beam formation and remodeling of woven bone into lamellar membranous bone tissue.
1. Introduction
According to world statistics, musculoskeletal injuries rank
second place among disability and mortality causes [1].
According to the forecast of Lopes et al., the annual fracture
number in Europe will increase by 28% by 2025 (from 3.5
to 4.5 million cases) [2]. Today, according to the WHO,
around 422 million people worldwide have diabetes mellitus
(DM). In the next 25 years, experts predict the rise of DM
incidence to 629 million, which is a major socioeconomic
problem [3, 4].
In total, the number of musculoskeletal injuries in
healthy persons’ clavicle fractures accounts for 17.5%; bra-
chial bone, 8.2%; forearm bones, 60.8%; femur, 8.2%; and
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lower leg bones, 5.2% [5]. Among DM patients and persons
with impaired glucose tolerance, forearm bone fractures
account for 21%; vertebrae, 18%; femur, 18%; and lower leg
bones, 19% [6]. Besides that, in DM patients, the proportion
of delayed fragment consolidation, fissures, and false joints
reaches from 8 to 32% compared to healthy individuals [7].
In recent years, autologous platelet concentrates have
been widely used in clinical practice for tissue regeneration
[8]. High efficiency of biological drugs based on platelet-
rich plasma (PRP) in sports injury treatment and during
operations on joints and bones in dentistry has been already
proved [9, 10]. However, there is insufficient information
about the efficacy and feasibility of PRP use in the treatment
of long tubular bone fractures in persons suffering from
chronic hyperglycemia or type 2 DM.
Therefore, unsatisfactory consequences of bone regenera-
tion disorders in DM patients, their high prevalence, compli-
cation number, and difficulties in treatment require further
study and deeper understanding of reparative osteogenesis
mechanisms under chronic hyperglycemia and finding new
effective and affordable approaches to their treatment.
The aim of this work was to study the histological, ultra-
microscopic, and histomorphometric features of reparative
osteogenesis in rats with chronic hyperglycemia, as well as
to investigate the possibility of PRP use in a fracture area to
correct the negative effects of chronic hyperglycemia on
reparative osteogenesis processes.
2. Materials and Methods
70 white laboratory male rats (age—7-9 months) were used
for experimental study. All animals were divided into the fol-
lowing groups: group I—control (animals with traumatic
injury of the tibia) (20 rats); group II—animals with experi-
mental CH and traumatic injury of the tibia (20 rats); group
III—rats with experimental CH and traumatic injury of the
tibia, which received PRP into the area of tibia fracture (20
rats); and group IV—animals for glucose homeostasis evalu-
ation and confirmation of modeled CH (10 rats).
All animals were examined for their motor activity and
condition of the outer covering. Then, rats were subjected
to two-week quarantine. Experimental animals were in con-
dition according to the general ethical principles of experi-
ments on animals (Kyiv, 2001), Declaration of Helsinki
(2000), and European Convention for the Protection of Ver-
tebrate Animals used for Experimental and Other Scientific
Purposes (Strasbourg, 1985). Ethics and morality were not
violated during the research. Rats were in the vivarium room
under constant temperature (24–25°C), humidity (60 ± 5) %,
and 12-hour dark-light cycle. Current cell cleaning was per-
formed daily.
CH in animals of groups II, III, and IV was modeled as
follows. For 2 weeks, rats have been consuming 10% aque-
ous fructose solution instead of drinking water. After that,
intraperitoneal administration of streptozotocin (Sigma-
Aldrich, USA) (40mg/kg) and nicotinic acid (1mg/kg) was
performed once for each rat. Control group animals were
administered single intraperitoneal injection of sterile citrate
buffer. Following the streptozotocin administration, animals
were kept under normal vivarium conditions on normal diet
for 60 days.
On the 60th day after CH modeling, fasting blood glu-
cose, insulin, glycosylated hemoglobin and C-peptide were
determined in animals of group IV. Acquired data was used
to confirm the CH presence.
Holey defect of both tibias was modeled in group I, II,
and III rats for further investigation of reparative osteogene-
sis at micro- and ultrastructural levels. Surgery was per-
formed in aseptic conditions under ketamine (8mg/kg) and
xylazine (3mg/kg) anesthesia. 30 minutes before surgery,
animals were intramuscularly administered a prophylactic
dose of ampicillin (7.5mg/kg). Preoperative preparation of
the surgical field was performed by shaving the wool in the
area of the anterior surface of the tibia and three times treat-
ing with 3% alcohol iodine solution.
Soft tissue sections of 0.8-1.5 cm long were made along
the margo anterior line of the tibia. Using a portable dental
drill (sterile boron (d 1.6mm), low revolutions with cooling)
formed port into the bone marrow in the middle third of the
tibial diaphysis. Surgical wounds were closed with skin suture
treated with 3% alcohol iodine solution.
In group I and II animals, the bone defect was left to heal
under the blood clot. In group III rats, in order to correct pos-
sible negative CH influence on reparative osteogenesis, PRP
(dose—0.5ml) was introduced into the wound before sutur-
ing. For this, previously, 2ml of blood from the lateral tail
vein was collected into 4ml vacuum containers containing
0.35ml of 10% sodium citrate solution. The lost blood vol-
ume was immediately restored by sterile saline infusion.
The selected blood was centrifuged for 20min at a speed of
2,000 rpm. As a result, two blood component fractions were
observed in the test tube: the lower dark red fraction (cellular
components) and the upper straw yellow fraction (serum
components). After that, the contents of the upper fraction
and upper portion of the lower fraction were pipetted and
transferred to another tube. The resulting material was cen-
trifuged for 15min at a speed of 2,000 rpm, which led to for-
mation of two fractions: the lower, platelet-rich plasma and
the upper, platelet-poor plasma. The contents of the lower
fraction were transferred to a sterile tube, and the volume
was adjusted to 1ml with 10% calcium chloride solution
[11]. The resulting solution was injected into the wounds
of animals.
Animals were removed from the experiment by the over-
dose of thiopental anesthesia (4mg/100 g body weight) on
the 14th and 30th day after trauma (these stages of bone heal-
ing process correspond to cell proliferation and differentia-
tion, bone formation, and its adaptive restructuring).
To study the microscopic structure, the prepared por-
tions of the left tibia with a defect were fixed in 10% formalin
solution. Then, demineralization was carried out in 5% aque-
ous Trilon B solution. Further samples were dehydrated in
alcohols of increasing concentration and poured into par-
affin. Then, using microtome MC-2, sections from obtained
preparations were made (thickness of 4-6μm). Staining was
performed with hematoxylin-eosin. An Olympus BH-2
microscope (Japan) was used for light microscopy. The
morphometric analysis was performed using a microgrid,
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microwave line, and Digimizer computing software (Ver-
sion 5.3.5). The following parameters were measured:
inflammatory infiltrate area (mm2), granulation tissue area
(mm2), connective tissue area (mm2), bone tissue area
(mm2), and cartilage area (mm2).
For ultramicroscopic examination using scanning elec-
tron microscopy, the injured right tibia of rats was removed
and fixed in 2.5% glutaraldehyde solution (in 0.2M cacody-
late buffer with pH = 7:2 at +4°C) and postfixed in 1%
OsO4 solution (for 4 hours at +4°C). Dehydration was done
using series of ethyl alcohol ascending concentrations. Before
examination, the specimens were sputtered with gold in vac-
uum post “VUP-5.” After that, specimens were placed in a
scanning electron microscope “REM 102” and photographed.
Statistical processing of all obtained numerical data was
performed using SPSS (version 17.0, Chicago, IL, USA). Val-
idation for normality of distribution was implemented using
the Kolmogorov-Smirnov criterion. Data are presented as
mean (M) and standard deviation (SD). The significance of
differences between two groups was determined using Stu-
dent’s criterion (t). The difference was considered significant
if the probability of chance (P) did not exceed 0.05 (P < 0:05).
3. Results
The blood metabolic parameters in groups I (control) and IV
(CH) are presented in Table 1. The fasting glucose (P < 0:001)
and glycosylated hemoglobin (P < 0:001) were significantly
higher in rats with CH compared to control animals. The
insulin level was decreased in the CH group (P = 0:020),
wherein the C-peptide amount was equal between two
groups (P = 0:267). Thus, the obtained results confirm the
presence of chronic hyperglycemia in experimental animals.
The histological and ultramicroscopic analysis of repara-
tive osteogenesis in the control group on the 14th day
revealed bone beams with clearly separated young lacunae
and fibroreticular tissue with high cell density of fibroblastic
and osteoblastic diferons. The electronic scans of the osteo-
genic beam surface revealed a large number of spherical
and cubic osteoblasts with long and thin processes. In most
trabeculae, osteoblasts were immobilized in their own matrix
(Figure 1(d)).
In animals with CH (group II), the defect area was filled
with connective tissue. No complete wound cleaning from
remnants of inflammatory infiltrate was observed. Local clus-
ters of neutrophilic granulocytes, macrophages, lymphocytes,
and adipocytes were localized in the central part of the defect
(Figure 1(b)). In addition, scattered groups of chondrogenic
cells were sometimes found among cellular infiltrates and
collagen fibers. Electron scans of bone regeneration samples
revealed clusters of rounded cells with numerous thin pro-
cesses. Single deformed erythrocytes and thin fibers have
been detected in the intervals between cell conglomerates
(Figure 1(e)).
In group III, the ordering and transformation of connec-
tive tissue into osteoid beams were noted. Most intensively,
this process took place near the maternal bone. The area of
connective tissue with a large number of sinusoidal-type cap-
illaries without signs of bone formation was observed in the
defect center (Figure 1(c)). Electronic scans of the regenerate
surface showed osteoblasts with thin long processes sur-
rounded by amorphous matrix (Figure 1(f)).
Figure 2 shows the tissue-specific composition of regener-
ate structures of bone defects on the 14th day of experiment.
The posttraumatic area in the control group consisted of con-
nective tissue (55.44%) and woven bone tissue (44.56%),
wherein residual signs of inflammation were retained in
CH rats. Inflammatory cell infiltration occupied 8.37% of
the entire osteoreparation zone and granulation tissue area,
9.99%. In contrast to control animals, the woven bone tis-
sue formation on the 14th day in CH animals did not
occur. Instead, cartilage islets were found (7.96% of the
total regenerated area). The rest of the regenerated area
was connective tissue (73.68%). In a group of animals,
which received PRP injection, the defect site was filled with
connective tissue (68.94%) and small bone trabeculae
(31.06%). No residual signs of inflammation, granulation,
and cartilage were detected.
On the 30th day of experiment, the bone defect in the
control group was almost completely filled with newly
formed bone tissue. At the same time, the processes of newly
formed woven bone tissue remodeling into lamellar mem-
branous bone tissue have begun. Active osteoclasts were
observed around the bone beams. The new lamellar membra-
nous bone tissue contained complete osteons with formed
Haversian canals. Most intensively, these processes occurred
near maternal bone. The central area of defect remained filled
with woven bone tissue (Figure 3(a)). Electronic scanning of
the defect area showed that its surface was covered with
newly formed bone, penetrated by numerous transcortical
vascular openings and osteoblastic lacunae (Figure 3(d)).
In group II, different sizes of osteogenic beams were
formed. Wide gaps were observed between the trabeculae.
Their formation near maternal bone was more structured.
There were areas with not fully formed and interconnected
beams. In the central part of defect, they had uneven thick-
ness and disorganized placement. In addition, there was local
replacement of defect by cartilage in the environment of
woven bone tissue (Figure 3(b)). The formation of lamellar
membranous bone tissue in this group did not occur. On
electronic scans, the surface of the defect site had numerous
intertrabecular gaps filled with cells and connective tissue.
The fibrous structure of osteogenic beams was well visual-
ized. Formation of complete periosteum of newly formed
bone did not occur (Figure 3(e)).
Table 1: The blood biochemical parameters in control and CH
groups.
Parameter Control (n = 10) CH (n = 10) Р
Fasting glucose (mmol/l) 4:89 ± 1:02 13:65 ± 2:21 <0.001
Insulin (μMU/ml) 14:86 ± 2:51 12:67 ± 1:05 0.020
С-peptide (ng/ml) 3:51 ± 0:56 3:37 ± 0:45 0.579
HbA1c (%) 5:50 ± 1:01 7:36 ± 0:52 <0.001
Abbreviations: CH: chronic hyperglycemia; HbA1c: glycosylated
hemoglobin. Data are presented as means ± SD.
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In group III animals, more than half of the tibial defect
was filled with woven bone tissue. Initial foci of lamellar
membranous bone formation with restored osteons and
Haversian canals were observed only near maternal bone
(Figure 3(c)). Scanning microcopy revealed that the surface
of defect central area was formed by massive collagen
strands. Osteoblasts immersed in an osteoid matrix of bone
beams were observed near maternal bone. The central zone
of defect was filled with woven bone tissue and connective
tissue. Regarding the periosteum, its formation on the
30th day of experiment in this group was just beginning
(Figure 3(f)).
Tissue-specific composition of bone regenerate structures
on the 30th day of experiment is shown on Figure 4. In the
control group, the defect area was filled with newly formed
woven bone and lamellar membranous bone tissues (total
area—84.44%). In rats with CH, the defect was filled with
woven bone tissue (61.54%), connective tissue (28.22%),
and cartilage tissue (10.24%). In group III, the formation of
lamellar membranous bone had only just begun. The defect
was mostly filled with woven bone (72.03%) and connective
tissue (27.97%).
4. Discussion
In recent years, approaches to treatment of musculoskeletal
injuries have changed significantly. According to ideas of
most current authors, the use of PRP is simple and affordable
and is a minimally invasive way to obtain natural concentra-
tion of autologous mediators, such as insulin-like growth fac-
tor-1, basic fibroblast growth factor, platelet-derived growth
factor, epidermal growth factor, vascular endothelial growth,
and transforming growth factor beta, which play a major role
in inflammatory response attenuation and necrotizing cell
elimination and have the number of potential advantages
over existing methods. The availability, simplicity, efficiency
of the method, and the absence of allergic reactions open
the prospects for its further study and wider use in clinical
medicine [8–10, 12, 13].
Research results report on high percentage (8 to 32%) of
reparative osteogenesis disorders in type 2 DM patients
and that hyperglycemia leads to decrease of proliferation
and differentiation of cartilage and osteoblastic diferon cells
involved in regeneration [14–17]. Our study revealed prolif-
eration and differentiation disorders of osteoblastic diferon
towards the formation of fibrocartilage regenerate in animals
with CH.
Marin et al. and Hygum et al. showed that CH causes
violation of coordinated action of signaling molecules and
regulators of reparative osteogenesis, which leads to decreas-
ing of osteoblast functioning, increasing of adipose tissue
amount in regenerates, and significant inhibition of consoli-
dation process [18, 19]. Our analysis of osteoreparation
stages revealed delay in elimination of the first phase of
inflammation in animals with CH. As a result, on the 14th
day, the regenerate in this group contained fat cells and sec-
tions of local lymphocytic-leukocyte infiltration.
Insulin plays the important role in bone healing in DM
patients through stimulation of bone matrix formation and
increasing of collagen synthesis by osteoblasts. In vitro
(a) (b) (c)
(d) (e) (f)
Figure 1: (a, d) Zone of tibial defect of control rats on the 14th day of reparative osteogenesis. (b, e) Zone of tibial defect of group II rats
(animals with CH) on the 14th day of reparative osteogenesis. (c, f) Zone of tibial defect of group III rats (animals with CH and PRP
injection) on the 14th day of reparative osteogenesis. (a–c) Hematoxylin and eosin stain. Magnification ×200. (d–f) Electronic scans.
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studies have identified decreasing of newly formed tissue ossi-
fication and impaired cartilage formation due to insulin defi-
ciency. Researchers have found that collagen synthesis level
in the fracture zone of DM rats decreased by 50-55%, which
led to deterioration of mechanical properties of newly formed
tissue [20]. In our study, we found impaired collagen structur-
ing into osteoid beams and uneven formation and placement
of cartilage in bone regenerates of animals with CH.
Dedukh and Sykal have reported about increasing of
osteoclast density, increasing of the chondroid area, disor-
ders of cartilage tissue replacement by bone, angiogenesis
defects, and collagen and glycosaminoglycan synthesis
impairment in the bone regenerate area of animals with
DM [21]. Besides, the fibroreticular tissue area in bone regen-
erates of DM animals was significantly higher compared to





















Figure 2: Areas of tissue-specific regenerate structures in bone defects of comparison groups on the 14th day of experiment: group I, control
animals; group II, animals with CH; and group III, animals that were injected with PRP after tibial injury; ∗statistically significant differences
between comparison groups (the control group was used as reference).
(a) (b) (c)
(d) (e) (f)
Figure 3: (a, d) Zone of tibial defect of control rats on the 30th day of reparative osteogenesis. (b, e) Zone of tibial defect of group II rats
(animals with CH) on the 30th day of reparative osteogenesis. (c, f) Zone of tibial defect of group III rats (animals with CH and PRP
injection) on the 30th day of reparative osteogenesis. (a–c) Hematoxylin and eosin stain. Magnification ×200. (d–f) Electronic scans.
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reparative osteogenesis processes. Our morphometric analy-
sis revealed that in animals with CH, the connective tissue
area on the 14th day of reparative osteogenesis was higher
by 18.24% (P < 0:001) and on the 30th day by 12.66%
(P < 0:001), compared to the control group.
Animals with CH have longer reparative osteogenesis
compared to animals with normal blood glucose. CH leads
to neoangiogenesis impairment and inflammation augmen-
tation, which finally cause disruption of osteogenic cell
proper distribution and inhibit oxygen and nutrient entry
to the regeneration zone. Also, tissue structure catabolism
disorders and proliferation of adipogenic cells are observed
in regenerated bone tissue of animals with DM. The above-
mentioned adipogenic cells increase the content of adipose
tissue in the fracture region, which leads to inhibition of bone
fragment consolidation [18, 22]. Our study confirms that
reparative osteogenesis process is longer in animals with
CH. On the 30th day of osteoreparation process, the area of
newly formed woven bone tissue in animals with CH was
22.89% (P < 0:001) less compared to control.
In group III (animals with CH, which were injected PRP
into the wound) on the 14th day of osteogenesis, residual
signs of inflammation, granulation, and cartilage tissues in
formed regenerates were not detected, unlike animals that
were not administered PRP. On the 30th day, the area of
woven bone tissue in regenerates of group III rats was larger
compared to that of animals with CH, which were not admin-
istered PRP. Obtained data confirm that PRP treatment
decreases damaged tissue swelling, inhibits acute inflamma-
tion, and promotes rapid shift from alteration phase to
regenerative-reparative processes [23].
The abovementioned data also indicates antimicrobial
activity of PRP, which is also shown in Bielecki et al. study
[24]. Authors have analyzed the antibacterial effect of PRP
in vitro. As a result, inhibition of Staphylococcus aureus
and Escherichia coli growth and simultaneous induction
of Pseudomonas aeruginosa growth were found. These
data demonstrates different resistance of microorganisms
to PRP. Authors believe that combination of inductive
and antimicrobial PRP properties may improve the treat-
ment outcomes of patients with infected fractures and
false joints.
It should be said that there are few important limitations
in our experiment, which did not allow us to evaluate the CH
and PRP effect on bone regeneration more efficiently. Special
staining methods with immunohistochemical reaction in
order to recognize osteoblasts, endotheliocytes, and different
types of leukocyte were not used. Thus, osteogenic cell
amount, neoangiogenesis degree, and inflammation nature
at the sites of bone regeneration were not accurately esti-
mated. In addition, we have not applied PCR and immuno-
histochemistry methods for quantitative and qualitative
assessment of molecular markers of bone regeneration (such
as osteocalcin, bone sialoprotein, bone morphogenetic pro-
tein-2, and Runx2), which also did not allow us to describe
the features of posttraumatic bone repair in different groups
at a molecular level.
5. Conclusions
Thus, the chronic hyperglycemia contributes to inflamma-
tion delay within the bone defect site, which makes the pro-
cess of reparative osteogenesis more prolonged. The results
of chronic hyperglycemia effect on bone regeneration are also
impairment of osteogenic cell proliferation and shift of their
differentiation towards the fibrocartilage regenerate forma-
tion. The PRP corrects the negative impact of chronic hyper-
glycemia on reparative osteogenesis, promoting more rapid
inflammatory infiltrate removal from bone defect site and
osteogenic beam formation and remodeling of woven bone




















Figure 4: Areas of tissue-specific regenerate structures in bone defects of comparison groups on the 30th day of experiment: group I, control
animals; group II, animals with CH; and group III, animals that were injected with PRP after tibial injury. aBone tissue—the summary area of
different types of bone tissue (woven bone and lamellar membranous bone, for groups I and III; woven bone, for group II). ∗Statistically
significant differences between comparison groups (the control group was used as reference).
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